Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Paul Lorigan
Based on 65 articles published since 2007
||||
Expertise Level
The expertise of Paul Lorigan ranks in the
  • Top 0.047%
  • ... of 100,393 published authors worldwide on Melanoma
  • ... from 2007 through 2018
  • ... based on contributions to 65 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Lorigan, P   ·   Lorigan, Paul
Work Locations
Details
Most likely:    University of Pittsburgh   Contact    
2017
  • From the University of Pittsburgh, Pittsburgh, PA; University of Manchester, Manchester, United Kingdom; Oregon Health & Science University, Portland, OR. · Pubmed 28561661
2018
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; The Christie NHS Foundation Trust, Manchester, UK; University of Pittsburgh Cancer Institute and School of Medicine, Pittsburgh, PA; Mayo Clinic Rochester, Rochester, MN; University of Tubingen, Tubingen, Germany; University of Edinburgh, Western General Hospital, Edinburgh, UK; Bristol-Myers Squibb, Wallingford, CT; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK; Universitas Brawijaya, Malang, Indonesia; IDDI, Louvain-la-Neuve, Belgium. · Pubmed 28922786
2010
  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. · Pubmed 20086001
Probable:    University of Manchester      
2017
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • From the University of Pittsburgh, Pittsburgh, PA; University of Manchester, Manchester, United Kingdom; Oregon Health & Science University, Portland, OR. · Pubmed 28561661
2016
  • From the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; St. Luke's University Hospital, Temple University, Allentown, PA; University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Pubmed 27249760
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • Growth Factor Signalling Laboratory, The Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · Division of Cancer Research, School of Medicine, University of Dundee, Dundee, United Kingdom. · Department of Respiratory, Inflammation and Autoimmunity Research, MedImmune Limited, Cambridge, United Kingdom. · Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands, Leiden University Medical Center, Einthovenweg, Leiden, Netherlands. · Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Withington, Manchester, United Kingdom. · Biological Services, The Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Department of Neurology, University Hospital Zurich, Frauenklinikstrasse, Zurich, Switzerland. · Colorectal Cancer and Wnt Signalling, The Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · The Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom. · Pubmed 27835901
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester. · The University of Manchester, The Christie NHS Foundation Trust, Manchester. · Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester. · Genomic Diagnostics Laboratory, Manchester Centre for Genomic Medicine, Central Manchester NHS Foundation Trust, Manchester, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester · Pubmed 27502704
  • Rockingham General Hospital, Cooloongup, Western Australia, Australia. · School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. · Olivia Newton- John Cancer Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia. · Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Victoria, Australia. · The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Box Hill Hospital, Box Hill, Victoria, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Pubmed 27124339
  • Medical Oncology, Christie NHS Foundation Trust, Manchester, UK. Electronic address: · Medical Oncology, Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK. · University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK; The Children's Brain Tumour Research Network, University of Manchester, UK. · Cancer Research UK Manchester Institute, University of Manchester, the Christie NHS Foundation Trust, Manchester, UK. · University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK; School of Medicine, University of Queensland, Brisbane, Australia. · Pubmed 26723549
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom. · The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Research Services, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Pubmed 26715644
2015
  • Christie NHS Foundation Trust, Manchester, UK. · Istituto Nazionale Tumori, Fondazione G Pascale, Napoli, Italy. · Karolinska Institutet, Stockholm, Sweden. · Clinica Universitaria de Navarra, Pamplona, Spain. · Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Institute of Cancer Sciences, Manchester M20 4BX, UK. Electronic address: · Pubmed 26433815
  • Rockingham General Hospital, Cooloongup, WA, Australia. · Christie NHS Foundation Trust and University of Manchester, Manchester, M20 4BX, UK. Electronic address: · Pubmed 26115798
  • Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK. · Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. · Department of Pathological Anatomy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. · Medical Oncology Service, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain. · Pathology Department, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain. · Medical Oncology Service, Vall d'Hebron University Hospital, Barcelona, Catalonia, Spain. · Dermatology Service, Hospital La Fe, Universidad de Valencia, Valencia, Spain. · Medical Oncology Service, Hospital General, Valencia, Spain. · Department of Pathology, University Hospital of Uppsala, Uppsala, Sweden. · Translational Cell &Tissue Pathology, Katholieke Universiteit Leuven, Leuven, Belgium. · University College Dublin School of Biomolecular and Biomedical Science, University College Dublin Conway Institute, University College Dublin, Belfield, Dublin, Ireland. · Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. · University of Manchester, Christie National Health Service Foundation Trust, Manchester, UK. · 1] Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. [2] Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. [3] Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. · Pubmed 26030178
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. · Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK. · Targeted Therapy Team, The Institute of Cancer Research, London SW3 6JB, UK. · Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK. · Histology Unit, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. · Signalling Networks in Cancer Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. · University of Manchester, Christie NHS Foundation Trust, Manchester M20 4BX, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. Electronic address: · Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK. Electronic address: · Pubmed 25500121
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK. · University of Manchester, Christie NHS Foundation Trust, Manchester, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK. Electronic address: · Pubmed 25178978
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2008
  • CRUK Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK. · Pubmed 18312390
2017
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; James Larkin, Royal Marsden Hospital, London; Paul Lorigan, University of Manchester, Manchester, United Kingdom; Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN; Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris; Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France; Benjamin Brady, Cabrini Health, Melbourne, Australia; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; Henrik Schmidt, Århus University, Åarhus, Denmark; Jessica C. Hassel, University Hospital Heidelberg, Heidelberg; Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude; Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver; Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada; Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL; and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
2014
  • 1Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK. · Pubmed 24667377
  • aClinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research bThe Christie NHS Foundation Trust cSchool of Cancer and Enabling Sciences, Manchester Cancer Research Centre and Manchester Academic Health Sciences Centre, University of Manchester, Manchester dAstraZeneca Pharmaceuticals, Alderley Park, UK. · Pubmed 24201293
2012
  • The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK. · Pubmed 23249108
Probable:    Oregon Health Sciences University   Contact    
2017
  • From the University of Pittsburgh, Pittsburgh, PA; University of Manchester, Manchester, United Kingdom; Oregon Health & Science University, Portland, OR. · Pubmed 28561661
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 65 total) written by Paul Lorigan about Melanoma:

  • Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy. 2018
  • Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017. 2017
  • Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis. 2017
  • Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy. 2017
  • Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis. 2017
  • Surgical Management and Adjuvant Therapy for High-Risk and Metastatic Melanoma. 2016
  • Survival of patients with advanced metastatic melanoma: The impact of novel therapies. 2016
  • Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells. 2016
  • Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA. 2016
  • Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy. 2016
Show List of Full Article Records
Google Searches

Learn more about Paul Lorigan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Pittsburgh
University of Manchester
Oregon Health Sciences University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Pittsburgh
2017
  • From the University of Pittsburgh, Pittsburgh, PA; University of Manchester, Manchester, United Kingdom; Oregon Health & Science University, Portland, OR. · Pubmed 28561661
2018
  • European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; The Christie NHS Foundation Trust, Manchester, UK; University of Pittsburgh Cancer Institute and School of Medicine, Pittsburgh, PA; Mayo Clinic Rochester, Rochester, MN; University of Tubingen, Tubingen, Germany; University of Edinburgh, Western General Hospital, Edinburgh, UK; Bristol-Myers Squibb, Wallingford, CT; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK; Universitas Brawijaya, Malang, Indonesia; IDDI, Louvain-la-Neuve, Belgium. · Pubmed 28922786
2010
  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. · Pubmed 20086001
University of Manchester
2017
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • From the University of Pittsburgh, Pittsburgh, PA; University of Manchester, Manchester, United Kingdom; Oregon Health & Science University, Portland, OR. · Pubmed 28561661
2016
  • From the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; St. Luke's University Hospital, Temple University, Allentown, PA; University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Pubmed 27249760
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • Growth Factor Signalling Laboratory, The Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · Division of Cancer Research, School of Medicine, University of Dundee, Dundee, United Kingdom. · Department of Respiratory, Inflammation and Autoimmunity Research, MedImmune Limited, Cambridge, United Kingdom. · Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands, Leiden University Medical Center, Einthovenweg, Leiden, Netherlands. · Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Withington, Manchester, United Kingdom. · Biological Services, The Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Department of Neurology, University Hospital Zurich, Frauenklinikstrasse, Zurich, Switzerland. · Colorectal Cancer and Wnt Signalling, The Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. · The Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom. · Pubmed 27835901
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester. · The University of Manchester, The Christie NHS Foundation Trust, Manchester. · Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester. · Genomic Diagnostics Laboratory, Manchester Centre for Genomic Medicine, Central Manchester NHS Foundation Trust, Manchester, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester · Pubmed 27502704
  • Rockingham General Hospital, Cooloongup, Western Australia, Australia. · School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. · Olivia Newton- John Cancer Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia. · Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Victoria, Australia. · The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Box Hill Hospital, Box Hill, Victoria, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Pubmed 27124339
  • Medical Oncology, Christie NHS Foundation Trust, Manchester, UK. Electronic address: · Medical Oncology, Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK. · University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK; The Children's Brain Tumour Research Network, University of Manchester, UK. · Cancer Research UK Manchester Institute, University of Manchester, the Christie NHS Foundation Trust, Manchester, UK. · University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Christie NHS Foundation Trust, Manchester, UK; School of Medicine, University of Queensland, Brisbane, Australia. · Pubmed 26723549
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom. · The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Research Services, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom. · Pubmed 26715644
2015
  • Christie NHS Foundation Trust, Manchester, UK. · Istituto Nazionale Tumori, Fondazione G Pascale, Napoli, Italy. · Karolinska Institutet, Stockholm, Sweden. · Clinica Universitaria de Navarra, Pamplona, Spain. · Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Institute of Cancer Sciences, Manchester M20 4BX, UK. Electronic address: · Pubmed 26433815
  • Rockingham General Hospital, Cooloongup, WA, Australia. · Christie NHS Foundation Trust and University of Manchester, Manchester, M20 4BX, UK. Electronic address: · Pubmed 26115798
  • Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK. · Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. · Department of Pathological Anatomy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. · Medical Oncology Service, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain. · Pathology Department, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain. · Medical Oncology Service, Vall d'Hebron University Hospital, Barcelona, Catalonia, Spain. · Dermatology Service, Hospital La Fe, Universidad de Valencia, Valencia, Spain. · Medical Oncology Service, Hospital General, Valencia, Spain. · Department of Pathology, University Hospital of Uppsala, Uppsala, Sweden. · Translational Cell &Tissue Pathology, Katholieke Universiteit Leuven, Leuven, Belgium. · University College Dublin School of Biomolecular and Biomedical Science, University College Dublin Conway Institute, University College Dublin, Belfield, Dublin, Ireland. · Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. · University of Manchester, Christie National Health Service Foundation Trust, Manchester, UK. · 1] Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. [2] Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. [3] Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. · Pubmed 26030178
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. · Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK. · Targeted Therapy Team, The Institute of Cancer Research, London SW3 6JB, UK. · Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK. · Histology Unit, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. · Signalling Networks in Cancer Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. · University of Manchester, Christie NHS Foundation Trust, Manchester M20 4BX, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. Electronic address: · Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK. Electronic address: · Pubmed 25500121
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK. · University of Manchester, Christie NHS Foundation Trust, Manchester, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK. Electronic address: · Pubmed 25178978
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2008
  • CRUK Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK. · Pubmed 18312390
2017
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; James Larkin, Royal Marsden Hospital, London; Paul Lorigan, University of Manchester, Manchester, United Kingdom; Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN; Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris; Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France; Benjamin Brady, Cabrini Health, Melbourne, Australia; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; Henrik Schmidt, Århus University, Åarhus, Denmark; Jessica C. Hassel, University Hospital Heidelberg, Heidelberg; Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude; Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver; Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada; Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL; and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
2014
  • 1Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK. · Pubmed 24667377
  • aClinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research bThe Christie NHS Foundation Trust cSchool of Cancer and Enabling Sciences, Manchester Cancer Research Centre and Manchester Academic Health Sciences Centre, University of Manchester, Manchester dAstraZeneca Pharmaceuticals, Alderley Park, UK. · Pubmed 24201293
2012
  • The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK. · Pubmed 23249108
Unspecified
2017
  • Birmingham Clinical Trials Unit, College of Medical and Dental Sciences, Public Health Building, University of Birmingham, Birmingham, B15 2TT, UK. · EORTC Headquarters, Avenue Emmanuel Mounier 83/11, 1200 Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · University of Pittsburgh Cancer Institute and School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA. · The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester, M20 4BX, UK. · Mayo Clinic Rochester, 200 First St. SW, Rochester, MN, 55905, USA. · University of Tubingen, Liebermeisterstraße 25, 72076, Tübingen, Germany. · Cancer Research UK Clinical Trials Unit, College of Medical and Dental Sciences, Robert Aitken Institute, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: · Pubmed 28692949
2015
  • Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester. · Clinical and Experimental Pharmacology, The Paterson Institute for Cancer Research, Manchester, UK. · Department of Medical Oncology, Charité Comprehensive Cancer Center, Berlin, Germany. · Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester Department of Medical Oncology, Charité Comprehensive Cancer Center, Berlin, Germany · Pubmed 24907634
  • Moffitt Cancer Center, Tampa, FL, USA. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · California Pacific Center for Melanoma Research, San Francisco, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Medizinische Hochschule Hannover, Hannover, Germany. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Medical University of Vienna, Vienna, Austria. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · University of Michigan, Ann Arbor, MI, USA. · Washington University, St Louis, MO, USA. · Centre Hospitalier Universitaire de Lyon, Lyon, France. · Christie Hospital, Manchester, UK. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · German Cancer Research Centre University Hospital, Heidelberg, Germany. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Yale Cancer Center, New Haven, CT, USA. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Elbe Kliniken Buxtehude, Buxtehude, Germany. · Department of Medicine, University of California, Los Angeles, CA, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA. · Department of Oncology, Herlev Hospital, Copenhagen, Denmark. · Aix-Marseille University, Hopital de la Timone, Marseille, France. · Technische Universität München School of Medicine, II Medical Department, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Bristol-Myers Squibb, Braine-I'Alleud, Belgium. · Royal Marsden Hospital, London, UK. · Pubmed 25795410
2014
  • Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Oxford National Institute for Health Research Biomedical Research Centre, Oxford, UK. · Medical Oncology, Mount Vernon Hospital, Northwood, Middlesex, UK. · Royal Marsden Hospital NHS Trust, London, UK. · Oncology Research, Broomfield Hospital, Chelmsford, UK. · Oncology Department, Leicester Royal Infirmary, Leicester, UK. · Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Newcastle upon Tyne, UK. · Cancer Research, St James's University Hospital, Leeds, UK. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Cancer and Palliative Care, St Helen's Hospital, St Helens, UK. · Oncology Department, Royal Surrey County Hospital, Surrey, UK. · Oncology Department, Royal Preston Hospital, Preston, UK. · Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Clinical Oncology, Norfolk and Norwich University Hospital, Norwich, UK. · Guy's and St Thomas' Hospital, London, UK. · Velindre Cancer Centre, Cardiff, UK. · Cambridge Cancer Trials Centre/Cambridge Clinical Trials Unit-Cancer Theme, Addenbrooke's Hospital, Cambridge, UK. · Deptartment of Medical Oncology, Christie Hospital, Manchester, UK. · Pubmed 24745696
  • School of Nursing, The Hong Kong Polytechnic University, Hong Kong School of Nursing, Midwifery and Social Work, University of Manchester, Manchester · School of Nursing, Midwifery and Social Work, University of Manchester, Manchester. · Christie NHS Foundation Trust, Manchester. · Institute of Inflammation and Repair, University of Manchester, Manchester, UK Cancer and Population Studies Group, QIMR Berghofer Medical Research Institute, Brisbane. · Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · St James's Institute of Oncology, Leeds. · Institute of Cancer Studies and Pathology, University of Leeds, Leeds, UK. · Pubmed 25081900
  • Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, U.K. · Pubmed 23855404
2015
  • The authors' affiliations are listed in the Appendix. · Pubmed 25891173
  • The authors' affiliations are listed in the Appendix. · Pubmed 25399551
  • Christie NHS Foundation Trust, Block C, Withington Hall Cotton Lane, Manchester, M20 4UX, UK, · Pubmed 25189151
2014
  • Department of aMedical Oncology bHematology, The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester, UK. · Pubmed 24992630
2013
  • Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, Manchester, UK. · Pubmed 23223143
2009
  • Cancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, Manchester, UK. · Pubmed 19367283
Oregon Health Sciences University
2017
  • From the University of Pittsburgh, Pittsburgh, PA; University of Manchester, Manchester, United Kingdom; Oregon Health & Science University, Portland, OR. · Pubmed 28561661
Netherlands Cancer Institute
2016
  • From the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; St. Luke's University Hospital, Temple University, Allentown, PA; University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Pubmed 27249760
2014
  • Netherlands Cancer Institute NKI-AVL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands, · Pubmed 24609989
Temple University
2016
  • From the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; St. Luke's University Hospital, Temple University, Allentown, PA; University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom. · Pubmed 27249760
Christie Hospital and Trust
2008
  • CRUK Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK. · Pubmed 18312390
2014
  • Miranda J. Payne, Katerina Argyropoulou, Cheng Han, Sandie Wellman, and Mark R. Middleton, National Institute for Health Research Biomedical Research Centre, Oxford University Hospitals National Health Service Trust, Oxford; Paul Lorigan, Christie Hospital, Manchester; James J. McAleer, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland; David Farrugia, Cheltenham Hospital, Cheltenham; Neville Davidson, Chelmsford Hospital, Chelmsford; Charles Kelly, Newcastle General Hospital, Newcastle upon Tyne; David Chao, Royal Free Hospital, Hampstead; and Ernest Marshall, Clatterbridge Centre for Oncology, Bebington, Wirral, United Kingdom. · Pubmed 24344211
  • aClinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research bThe Christie NHS Foundation Trust cSchool of Cancer and Enabling Sciences, Manchester Cancer Research Centre and Manchester Academic Health Sciences Centre, University of Manchester, Manchester dAstraZeneca Pharmaceuticals, Alderley Park, UK. · Pubmed 24201293
42 Other Locations Show
Yearly article counts 14711139635312
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.